Scrip Regulatory Affairs
The New EU Data Protection Regulation: What will the Impact be on the Life Sciences Industry?
March 2012
The EU Data Protection Regulation proposed by the European Commission in January will - if adopted in its current form - require pharmaceutical and medical device companies to adopt a new approach to data processing and data protection.
This article was published in the March 2012 issue of Scrip Regulatory Affairs.
Contacts
Capabilities
Suggested News & Insights
Sidley Represents Liberty Mutual in US$750 Million Senior Notes OfferingApril 23, 2026Sidley Represents ModMed in Its Acquisition of Bonsai HealthApril 22, 2026U.S. SEC Clears Path for Decentralized Crypto Asset Security Trading With Broker Registration Exception for User InterfacesApril 21, 2026UK Operational Incident and Third-Party Reporting Rules: What Firms Should Do NowApril 16, 2026Chambers 2026 Global Practice Guide for CybersecurityApril 15, 2026Regulatory Update: National Association of Insurance Commissioners Spring 2026 National MeetingApril 14, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory
